PROTECT Takeaways
Emisphere’s proprietary carrier was effective
Our unique oral drug delivery technology remains of critical interest to Big Pharma as a means to enhance their current franchises
Platform is intact and technology is sound
Viable technology that can be applied to other candidates
Significantly enhanced safety database
Safety and efficacy database available for future solid heparin dosage products